Epilepsy and pregnancy: Minimizing the risks

Contemporary Ob/Gyn

Volumn 49, Issue 1, 2004, Pages 51-70

  Morrell, Martha J ^a,b  

^a Columbia University ^*  (United States)

^b NewYork Presbyterian System Select Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 15244361068     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Morrell MJ Reproductive and metabolic disorders in women with epilepsy. Epilepsia. 2003;44(suppl 4);S11-S20.
2. Schmidt D, Beck-Mannagetta G, Janz D, et al. The effect of pregnancy on the course of epilepsy: a prospective study. In: Janz D, Dam M, Richens A, eds. Epilepsy, Pregnancy, and the Child. New York, NY: Raven Press; 1982:39-49.
3. Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia, 1975;16:99-110.
4. Morrell MJ. Hormones and epilepsy through the lifetime. Epilepsia. 1992;33(suppl 4):S49-S61.
5. Herzog AG. Reproductive endocrine considerations and hormonal therapy for women with epilepsy. Epilepsia. 1991;32(suppl 6):S27-S33.
6. Sabers A, ARogvi-Hansen B, Dam M, et al. Pregnancy and epilepsy: a retrospective study of 151 pregnancies. Acta Neurol Scand. 1998;97:164-170.
7. Zahn CA, Morrell MJ, Collins SD, et al. Management Issues for women with epilepsy: a review of the literature. Neurology. 1998, 51:949-956.
8. Tomson T, Lindbom U, Ekqvist B, et al. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia. 1994;35:122-130.
9. Gjerde IO, Strandjord RE, Ulstein M. The course of epilepsy during pregnancy: a study of 78 cases. Acta Neurol Scand. 1988;78:198-205.
10. Crawford P. CPD Education and self-assessment: Epilepsy and pregnancy. Seizure. 2001;10:212-219.
11. Pack AM, Morrell MJ. Treatment of women with epilepsy. Semin Neurol. 2002;22:289-2987.
12. Morrell MJ. Epilepsy in women: the science of why it is special. Neurology. 1999;53(4 suppl 1):S42-S48.
13. Herzog AG, Klein P, Ransil BJ. Three patterns of cata-menial epilepsy. Epilepsia. 1997;38:1082-1088.
14. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand. 1976;54:321-347.
15. Shavit G, Lerman P, Korczyn AD, et al. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology. 1984;34:959-961.
16. Rosciszewska D, Buntner B, Guz I, et al. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry. 1986;49:47-51.
17. Al-Bunyan MA. Random total antiepileptic drug levels and seizure control during pregnancy. Saudi Med J. 2001;22:355-359.
18. Otani K. Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatr Neurol Jpn. 1985;39:33-41.
19. Schmidt D, Canger R, Avanzini G, et al. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry. 1983;46:751-755.
20. Foldvary N. Treatment issues for women with epilepsy. Neurol Clin. 2001;19:409-425.
21. Bardy AH. Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study. Acta Neurol Scand. 1987;75:356-360.
22. Bardy AH. Seizure frequency in epileptic women during pregnancy and puerperium: results of the prospective Helsinki study. In: Janz D, Dam M, Richens A, et al, eds. Epilepsy, Pregnancy, and the Child. New York, NY: Raven Press; 1982:27-37.
23. Katz JM, Devinsky O. Primary generalized epilepsy: a risk factor for seizures in labor and delivery? Seizure. 2003;12:217-219.
24. Yerby M, Koepseall T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia. 1985;26:631-635.
25. Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology. 1998;51:904-906.
26. Tettenborn B, Genton P, Poison D. Epilepsy and women's issues: an update. Epileptic Disord. 2002;4(suppl 2):S23-S32.
27. Higgins TA, Comerford JB. Epilepsy in pregnancy. J Ir Med Assoc. 1974;67:317-320.
28. Schupf N, Ottman R. Reproduction among individuals with idiopathic/cryptogenic epilepsy: risk factors for spontaneous abortion. Epilepsia. 1997;38:824-829.
29. Devinsky O, Yerby MS. Women with epilepsy. Reproduction and effects of pregnancy on epilepsy. Neurol Clin. 1994;12:479-495.
30. Comelissen M, Steegers-Theunissen R, Kollee L, et al. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy. Am J Obstet Gynecol. 1993;168:923-928.
31. Thorp JA, Gaston L, Caspers DR, et al. Current concepts and controversies in the use of vitamin K. Drugs. 1995;49:376-387.
32. Dravet C, Julian C, Legras C, et al. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology. 1992;42(4 suppl 5):S75-S82.
33. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1998;51:944-948.
34. Samrén EB, van Duijn CM, Christiaens GC, et al. Antiepileptic drug regimens and major congenital abnormalities In the offspring. Ann Neurol. 1999;46:739-746.
35. Steegers-Theunissen RP, Renier WO, Borm GF, et al. Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multicentre prospective study. Epilepsy Res. 1994;18:261-269.
36. Koch S, Losche G, Jager-Roman E, et al. Major and minor birth malformations and antiepileptic drugs. Neurology. 1992;42(4 suppl 5):S83-S88.
37. Shapiro S, Hartz SC, Siskind V, et al. Anticonvulsants and parental epilepsy in the development of birth defects. Lancet. 1976;1:272-275.
38. Hanson JW, Myrianthopoulos NC, Harvey MA, et al. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr. 1976;89:662-668.
39. Gaily E, Kantola-Sorsa E, Granstrom ML. Intelligence of children of epileptic mothers. J Pediatr. 1988;113:677-684.
40. Wide K, Winbladh B, Tomson T, et al. Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study. Dev Med Child Neurol. 2000;42:87-92.
41. Barrett C, Richens A. Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop. Epilepsy Res. 2003;42:147-187.
42. Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001;344:1132-1138.
43. Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology. 2003;60:575-579.
44. Friis ML, Holm NV, Sindrup EH, et al. Facial clefts in sibs and children of epileptic patients. Neurology. 1986;36:346-350.
45. Mawer G, Clayton-Smith J, Coyle H, et al. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure. 2002;11:512-518.
46. Karceski S, Morrell M, Carpenter D. The expert consensus guidelines series: treatment of epilepsy. Epilepsy Behav. 2001;2:A1-A50.
47. Beghi E, Annegers JF. Collaborative Group for the Pregnancy Registries in Epilepsy. Pregnancy registries in epilepsy. Epilepsia. 2001;42:1422-1425.
48. Tennis P, Eldridge RR. International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia. 2002;43:1161-1167.
49. Lamotrigine Pregnancy Registry. Interim Report: September 1992 through March 2003. PharmaResearch Corporation, Research Park, Wilmington, NC.
50. Morrow JI, Russell A, Craig JJ, et al. Major malformations in the offspring of women with epilepsy: a comprehensive prospective study. Epilepsia. 2001:42(suppl 2):S125.
51. Holmes LB, et al. Evidence of increased risk of birth defects in offspring of women exposed to phenobarbital as a monotherapy. Teratology.2001;63:250.
52. Holmes LB, et al. Evidence of increased risk of birth defects in offspring of women exposed to valproate (Depakote, Depakene, Epival). Am J Obstet Gynecol. 2002;187(suppl):S137.
53. American Academy of Pediatrics Committee on Drugs:. The transfer of drugs and other chemicals into human milk. Pediatrics. 1994;93:137-150.
54. Guidelines for the care of women of childbearing age with epilepsy. Commission on Genetics, Pregnancy, and the Child, International League Against Epilepsy. Epilepsia. 1993;34(4):588-589.
55. Hagg S, Spigset O. Anticonvulsant use during lactation. Drug Saf. 2000;22:425-440.
56. Bar-Oz B, Nulman I, Koren G, et al. Anticonvulsants and breast-feeding: a critical review. Paedlatr Drugs. 2000;2:113-26.
57. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia. 2000;41:709-713.
58. Ohman I, Vitols S, Luef G, et al. Topiramate kinetics during delivery, lactation, and in the neonate; preliminary observations. Epilepsia. 2002;43:1157-1160.
59. Myllynen P, Pienimaki P, Jouppila P, et al. Transplacental passage of oxcarbazepine and its metabolites in vivo. Epilepsia. 2001;42:1482-1485.
60. Henshaw SK. Unintended pregnancy in the United States. Earn Plann Perspect 1998;30:24-29, 46.
61. Bell GS, Nashef L, Kendall S, et al. Information recalled by women taking anti-epileptic drugs for epilepsy: a questionnaire study. Epilepsy Res. 2002;52:139-146.
62. Tran TA, Leppik IE, Blesi K, et al. Lamotrigine clearance in pregnancy. Neurology. 2002;59:251-255.
63. Seizure disorders in pregnancy. American College of Obstetric and Gynecologic Physicians Educational Bulletin. 1996;231:1-13.
64. Van Allen Ml, Fraser FC, Dallaire L, et al. Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists. CMAJ. 1993;149:1239-1243.
65. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41:1-7.
66. Oguni M, Dansky L, Andermann E, et al. Improved pregnancy outcome in epileptic women in the last decade: relationship to maternal anticonvulsant therapy. Brain Dev. 1992;14:371-380.